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Abstract
Background: Development of human tissue is influenced by a combination of intrinsic biological signals and
extrinsic environmental stimuli, both of which are mediated by epigenetic regulation, including DNA methylation.
However, little is currently known of the normal acquisition or loss of epigenetic markers during fetal and postnatal
development.
Results: The DNA methylation status of over 1000 CpGs located in the regulatory regions of nearly 800 genes was
evaluated in five somatic tissues (brain, kidney, lung, muscle and skin) from eight normal second-trimester fetuses.
Tissue-specific differentially methylated regions (tDMRs) were identified in 195 such loci. However, comparison with
corresponding data from trisomic fetuses (five trisomy 21 and four trisomy 18) revealed relatively few DNA
methylation differences associated with trisomy, despite such conditions having a profound effect on
development. Of interest, only 17% of the identified fetal tDMRs were found to maintain this same tissue-specific
DNA methylation in adult tissues. Furthermore, 10% of the sites analyzed, including sites associated with imprinted
genes, had a DNA methylation difference of >40% between fetus and adult. This plasticity of DNA methylation
over development was further confirmed by comparison with similar data from embryonic stem cells, with the
most altered methylation levels being linked to domains with bivalent histone modifications.
Conclusions: Most fetal tDMRs seem to reflect transient DNA methylation changes during development rather
than permanent epigenetic signatures. The extensive tissue-specific and developmental-stage specific nature of
DNA methylation will need to be elucidated to identify abnormal patterns of DNA methylation associated with
abnormal development or disease.
Background
The human body contains more than 200 different cell
types, each having developed a different function and
phenotype despite containing an identical genome.
Through the establishment and maintenance of cell
type-specific gene expression profiles, epigenetic
mechanisms contribute to cellular identity [1]. Perhaps
the best understood component of the epigenetic
machinery is DNA methylation, which most often
occurs on cytosine residues in the context of CpG
dinucleotides.
In addition to tissue-specific gene expression, there
was a number of intriguing biological phenomena
closely linked to DNA methylation, including inactiva-
tion of the extra X-chromosome in females [2], allele-
specific expression of imprinted genes [3], and biological
aging [4,5]. All of these processes are examples of devel-
opmental programming of DNA methylation, which are
generally considered to be relatively stable. However,
recent studies have shown that DNA methylation can be
dynamic and capable of temporally changing [6,7]. This
plasticity may be modulated in part by a diverse set of
environmental influences, all of which have been corre-
lated with changes in DNA methylation. These include
nutritional factors such as folate intake [8], social factors
such as maternal care [9], and environmental factors
such as exposure to pollutants [10,11]. Therefore, it is
likely that DNA methylation serves as an important
mediator between the environment and genome func-
tion. The malleable features of DNA methylation are
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any medium, provided the original work is properly cited.important for its role in health and disease, as improper
regulation of this epigenetic marker during development
has been associated with a number of pathological con-
ditions including birth defects and various cancers [12].
One particularly well-understood specialized aspect of
epigenetics during development is genomic imprinting,
which describes the specific allelic expression, depending
on the parent of origin, of a small number of genes.
Although this epigenetic program is established early in
development and thought to be maintained throughout
life [13,14], relatively little is known about its tissue-spe-
cific features and temporal dynamics in different devel-
opmental stages in humans. In addition to imprinting, a
number of findings connecting DNA methylation
changes to biological development have emerged over
the past few years, largely fuelled by the advent of gen-
ome-wide technologies. For example, substantial altera-
tions in DNA methylation occur during stem cell
differentiation, supporting a general role for DNA
methylation in early development [15-17]. Similarly, pro-
filing of adult human tissues has shown striking differ-
ences in DNA methylation, particularly in tissue-specific
differentially methylated regions (tDMRs) [18-21]. DNA
methylation in adult somatic tissues can undergo strik-
ing changes during the adult lifespan, with a tendency
for gain of DNA methylation with age for loci (CpG
sites) residing within CpG islands (CGIs), and loss of
DNA methylation with age for CpG loci residing outside
CGIs [22]. It has not yet been determined whether such
changes reflect instability in the maintenance of DNA
methylation over time, leading to more variable methy-
lation in the older samples, or alternatively, are indica-
tive of intrinsic programmed changes over time, due to
changing biological requirements at different develop-
mental and life stages.
It is also not clear to what extent epigenetic program-
ming may be altered by the abnormal development of
cells and tissues. Dramatic changes in DNA methylation
occur in connection with the altered cellular changes in
cancer [23,24]. Reminiscent of cancer, chromosomal
trisomy is also associated with altered cell-growth para-
meters (generally slower growth and increased apopto-
sis) and a global disruption of the transcriptome [25-27],
which could be similarly be associated with altered DNA
methylation of a subset of genes. However, comprehen-
sive mapping of DNA methylation has not been per-
formed in subjects with trisomy, especially as it relates
to tissue-specific features.
Mechanistically, DNA methylation exerts its effects on
gene expression in close partnership with histone pro-
teins [28]. DNA methylation is sensed by proteins that
turn on or off gene expression, often through altering
post-translational modifications of histones. Numerous
histone modifications are associated with different levels
of gene expression, most prominently H3K4 trimethyla-
tion as an indicator of active transcription, and H3K27
trimethylation as an indicator of inactive genes. Cur-
iously, in stem cells, these markers are sometimes found
together in ‘bivalent domains’,w h i c hm i g h tp o i s eg e n e s
for the rapid expression changes necessary during devel-
opment [29].
In this study, we investigated the characteristics and
functional significance of the differentially methylated
C p Gl o c ii nn o r m a la n da b n o r m a lf e t a ld e v e l o p m e n t .
Using a well-validated array platform, the DNA methyla-
tion status of around 1000 CpG dinucleotides located in
the regulatory regions of nearly 800 genes was measured
semi-quantitatively in five somatic tissues (brain, kidney,
lung, muscle and skin) from second-trimester elective
terminations of eight normal, five trisomy 21 (T21) and
four trisomy 18 (T18). We found tissue-specific cluster-
ing of DNA methylation at this early stage of develop-
ment in all fetuses, whereas relatively few sites with
altered DNA methylation were seen for trisomies.
Through a detailed comparison of fetal DNA methyla-
tion data with published data on normal somatic tissues
from adult autopsies obtained on an identical platform
[30], we identified substantial age-related changes in
DNA methylation. Lastly, the plasticity of DNA methy-
lation was also evident when we compared fetal DNA
methylation profiles to embryonic stem cells [31], with
the most variable markers being linked to domains with
bivalent histone modifications. Collectively, these data
fill an important gap between DNA methylation patterns
in stem cells and in adult tissues, and illustrate the com-
plexity that may arise in trying to identify subtler effects
of environment or disease.
Results
Tissue-specific DNA methylation in fetal tissues
To determine the extent of tissue-specific DNA methy-
lation during fetal development, we used a well-validated
array (GoldenGate DNA Methylation Cancer Panel I;
Illumina Inc., San Diego, CA, USA) to measure the
DNA methylation status in five somatic tissues (brain,
kidney, lung, muscle and skin) from second-trimester
elective terminations of eight normal, five T21 and four
T18 fetuses. For each sample, relative DNA methylation
was measured at 1315 CpG loci located in the promoter
regions of 752 genes after eliminating probes with a
detection P value of > 0.05 and those located on the X-
chromosome. Only CpG loci located on autosomes were
included in the analysis to eliminate gender-specific
effects caused by differential methylation of the X-chro-
mosome, which tends to be hypermethylated at gene-
regulatory regions in females [32,33].
Unsupervised hierarchical clustering (Beadstudio soft-
ware; Illumina) of the remaining 877 CpG loci was
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the correlation coefficient between sample methylation
values at the included loci. The methylation profiles for
samples of the same tissue type were strongly correlated
(r > 0.925) and therefore clustered together (Figure 1;
see Additional file 1, Figure S1), with the most distinct
clustering found for brain. All samples clustered
together with strong correlation between samples
derived from the same tissue, except for one T21 muscle
sample (FT1_t21_muscle), which clustered with the skin
sample from the same fetus.
The tight clustering of tissues enabled the identifica-
tion of CpG loci with tissue-specific DNA methylation
profiles. To eliminate potential confounding factors
resulting from chromosomal trisomy, this analysis was
confined to the five somatic tissues (brain, kidney, lung,
muscle and skin) from the eight normal fetuses. Of the
834 sites studied after elimination of invariable sites
between normal tissues (see Methods), 195 (23%) were
found to be significantly different between tissues as
determined by one-way analysis of variance (ANOVA)
using a Bonferroni corrected P value of 5.99 × 10
-5 (see
Additional file 2, Table S1).
Of the 195 tDMRs, only 63 (32%) were located within
a CpG island (CGI; defined as GC content >50% and
observed/expected CpG >0.6 in a length of >200 bp). By
contrast, 586 (70%) of the original 834 sites tested were
associated with CGIs, suggesting that low-density CpG
regions are more likely to dictate tissue-specific DNA
methylation patterns (P < 0.0001; c
2 test).
To identify the changes that are most likely to be bio-
logically meaningful, we selected for subsequent analysis
98 tDMRs that had an absolute difference in average
DNA methylation level for a given CpG site of at least
20% in a particular tissue. Hypermethylated and hypo-
methylated loci were thus defined as those having an
average b value in that tissue of >0.2 above or below the
overall mean for all tissues (a b value of 0 represents an
unmethylated locus and a value of 1 represents a com-
pletely methylated locus). Using this cut-off, fetal brain
had the highest number of tDMRs (Figure 2), with 30
hypermethylated and 23 hypomethylated loci, consistent
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Figure 1 Unsupervised clustering of fetal tissues demonstrates that each tissue has a distinct DNA methylation profile. Sample names
are shown with labelling of the corresponding tissue types. Tissue samples were clustered by hierarchical clustering of b values based on the
formula 1-r (Beadstudio software; Illumina), where r is the correlation coefficient between samples. Specific tissue types clustered together, with
strong correlation between samples derived from the same tissue. All tissues had distinct clustering from the other groups, except for one
muscle sample from T21 (FT1_t21_muscle), which clustered with the skin sample from the same fetus.
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(Figure 1). Muscle was the next most distinct tissue,
with 24 hypermethylated and 16 hypomethylated tDMRs
(see Additional file 2, Table S1).
T h ea b i l i t yt oi d e n t i f yt h et i s s u es o u r c eo fD N As a m -
ples could be useful in determining the developmental
origin of pathologically abnormal tissue or other sam-
ples of unclear origin. To identify sites that could be
u s e da sk e yi n d i c a t o rm a r k e r st oi d e n t i f yt i s s u es o u r c e ,
we searched for sites within the fetal tissue data for
which the mean of one tissue was maximally different
from the mean for other tissues, and in addition, did
not show any overlap in the range of DNA methylation
values. Using these more stringent criteria, one locus
with tissue-specific DNA methylation was identified
for each tissue type (five in total: CDH17_E31 for
kidney, CRK_P721 for lung, HOXA5_P479 for skin,
MUSK_P308 for muscle and MEST_P4 for brain) (see
Additional file 2, Table S1). This tissue specificity was
confirmed with bisulfite pyrosequencing, with the corre-
lation between values from the microarray and pyrose-
quencing ranging from r = 0.77 to r = 0.97 (see
Additional file 1, Figure S2). These loci are associated
with genes (within the promoter region as defined by
the Illumina annotation) that are important for the
development of their respective tissues [34-36]. For
example, MUSK_P208 is associated with the MUSK
(muscle skeletal receptor tyrosine kinase) gene, which is
responsible for synapse formation in mammalian muscle
during development [36].
DNA methylation in somatic tissues from T21 and T18
fetuses had relatively few differences from those of
normal fetuses
To identify potential epigenetic differences associated
with chromosomal trisomies, the DNA methylation pro-
file in the five somatic tissues (brain, kidney, lung, mus-
cle and skin) from the eight normal fetuses (three male,
five female) was compared with the identical tissues
from the fetuses with either T18 (n = 4; three male, one
female) or T21 (n = 5; two male, three female). Using a
cut-off of <5% false discovery rate (FDR) from signifi-
cance analysis of microarrays (SAM) [37] and a pre-
viously suggested Δb value of >0.17 [38], we identified
17 hypermethylated loci in T18 skin, seven in T21 skin,
and one in T21 muscle (Table 1). None of these loci
were located on chromosomes 18 or 21. One CpG
(DDB2_P407) was hypermethylated in both skin and
Figure 2 Heat-map of 98 loci showing hypermethylated or hypomethylated tissue-specific differentially methylated regions (tDMRs) in
particular tissues. Probes and sample names are shown and with hierarchical clustering of b values based on the formula 1-r (Beadstudio
software; Illumina), where r is the correlation coefficient between samples. A b value of 0 (bright green) represents an unmethylated locus, and a
value of 1 (bright red) represents a methylated locus. Hypermethylated and hypomethylated loci were defined as those having an average b
value in that tissue of >0.2 above or below the overall mean for all tissues. Fetal brain had the highest number of tDMRs, with 30
hypermethylated and 23 hypomethylated loci.
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hypermethylated in T18 and T21 skin (Table 1). No dif-
ferentially methylated loci were identified in brain, kid-
ney or lung. Furthermore, the tDMRs identified as key
indicators of normal fetal tissue types maintained their
tissue-specific DNA methylation patterns in the trisomy
samples (data not shown). Thus, the significant differ-
ences in DNA methylation between chromosomally nor-
mal and abnormal fetuses were largely tissue-specific
and limited compared with the total number of tissue-
specific differences observed.
DNA methylation of a significant portion of CpG loci was
age-dependent
The establishment of semi-quantitative DNA methyla-
tion maps from the fetuses studied allowed us to deter-
mine the extent of age-dependent DNA methylation
changes. To this end, we compared our data with pub-
lished DNA methylation measurements obtained from
adult human autopsy specimens using the same methy-
lation array [30]. This analysis was limited to the three
tissues that overlapped between the two studies (brain,
kidney and lung). After eliminating all non-variable CpG
loci in the combined fetal plus adult tissue group (b
value <0.1 or >0.9 in all samples), 756 loci in brain,
1026 loci in kidney and 849 loci in lung were compared.
In general, the average DNA methylation at each auto-
somal locus in normal fetal tissues correlated more
strongly with the average DNA methylation for the cor-
responding locus in the trisomic fetal tissues (r = 0.99)
than the comparable adult tissues (Additional file 1,
Figure S3).
To identify significantly altered sites between fetal and
adult tissues, we analyzed raw CpG methylation data using
stringent criteria (FDR <5% and Δb >0.4). This high cut-
off for average DNA methylation difference (more than
double the suggested b value difference of 0.17) was used
to avoid any discrepancies arising from signal differences
between arrays due to different hybridization efficiencies
or different laboratory facilities performing the experi-
ments [38]. Using this approach, we identified 89 CpG
loci, representing 75 distinct genes, for which DNA
methylation status was different between fetal and adult
tissues. We refer to these as age-dependent (a)DMRs.
Table 1 Loci showing differential DNA methylation between trisomic and control subjects
Controls Trisomies
Type Tissue Feature ID Chromosome FDR
a, % Mean SD Mean SD Difference GO
b term
T18 Skin HOXA9_E252_R 7 0 0.04 0.09 0.58 0.21 0.54 Developmental process
ZNF264_P397_F 19 0 0.52 0.17 0.92 0.01 0.40 Biological regulation
RYK_P493_F 3 0 0.17 0.08 0.56 0.12 0.39 Developmental process
CASP10_P186_F 2 0 0.37 0.12 0.72 0.11 0.35 Developmental process
IL1RN_P93_R 2 0 0.51 0.07 0.78 0.04 0.27 Immune response
RBL2_P250_R 16 0 0.04 0.05 0.26 0.11 0.22 Biological regulation
MAP2K6_P297_R 17 0 0.30 0.05 0.49 0.03 0.19 Metabolic process
JAK3_P156_R 19 0 0.25 0.05 0.44 0.07 0.19 Developmental process
MST1R_P392_F 3 0 0.15 0.05 0.32 0.05 0.17 Metabolic process
RARA_P1076_R 17 2.08 0.19 0.08 0.52 0.19 0.33 Metabolic process
CPA4_E20_F 7 2.08 0.37 0.07 0.61 0.13 0.24 Metabolic process
CEACAM1_E57_R 19 2.08 0.27 0.05 0.46 0.09 0.19 Developmental process
ARHGDIB_P148_R 12 3.38 0.74 0.10 0.92 0.02 0.19 Immune response
SEPT9_P374_F 17 4.24 0.14 0.08 0.37 0.15 0.24 Immune response
S100A4_E315_F 1 4.24 0.25 0.09 0.43 0.10 0.19 Developmental process
RAD54B_P227_F 8 4.24 0.16 0.05 0.33 0.12 0.17 DNA repair
CASP10_E139_F 2 4.24 0.74 0.10 0.92 0.01 0.17 Developmental process
T21 Skin ZNF264_P397_F 19 0 0.52 0.17 0.85 0.06 0.33 Biological regulation
WNT10B_P993_F 12 0 0.16 0.04 0.38 0.08 0.22 Developmental process
DIO3_E230_R 14 0 0.45 0.11 0.65 0.05 0.19 Biological regulation
TSC2_E140_F 16 0 0.61 0.06 0.79 0.08 0.18 Biological regulation
IPF1_P750_F 13 3.89 0.33 0.12 0.56 0.12 0.23 Biological regulation
DDB2_P407_F 11 3.89 0.12 0.09 0.35 0.16 0.23 DNA repair
HLA-DRA_P77_R 6 3.89 0.70 0.10 0.87 0.05 0.17 Immune response
T21 Muscle DDB2_P407_F 11 0 0.11 0.05 0.30 0.08 0.19 DNA repair
aFalse discovery rate.
bGene ontology.
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the DNA methylation arrays (GoldenGate) used in the
two studies (Figure 3A,B; Table 2; see Additional file 2,
Table S2). Of these, only four loci (ALOX12_P223,
APC_E117, GABRB3_P92 and PEG3_E496) had significant
(using our criteria) age-related changes in all three tissues.
More commonly, the aDMRs were specific for one tissue,
with 24 such loci identified in brain, 11 in kidney and 25
in lung (Figure 3A). Interestingly, these differentially
methylated loci included some imprinted regions, such as
GABRB3, ZNF264 and PEG3 (see Additional file 1, Figure
S4A-C), in which DNA methylation is believed to play a
central role in regulating allelic expression in a parent-of-
origin manner during normal development [39-41]. There
were also many immune-related genes (for example,
human leukocyte antigen class II genes) that were hyper-
methylated in fetal compared with adult tissue, presum-
ably reflecting that the immune system is not yet
developed fully in the fetus [42].
Together, these data suggest that fetal-to-adult pro-
grammed DNA methylation changes occur in a variety
of genes within specific tissues. To examine this tissue
specificity in more detail, we next focused on comparing
tDMRs between fetal and adult tissues. Although a simi-
lar number of tDMRs was identified in fetus and adult
(93 and 82, respectively), only 25 of these were common
to both (see Additional file 2, Table S3). Moreover, of
the 25 loci identified as tDMRs in both fetus and adult,
only 16 had the same relative tissue-specific DNA
methylation pattern in both. Thus, only ~17% (16 of 93)
of the fetal tDMRs remained as clear tDMRs in adult
tissues. Similarly, 57 tDMRs in adult were not identified
as differentially methylated in fetus (see Additional file
1, Figure S5). For example, PTPN6_E171 showed kid-
ney-specific hypomethylation in adult, but was hypo-
methylated in all the tissues examined (brain, kidney,
lung, skin and muscle) in fetus. Furthermore, the fetal
tissue-specific indicative loci MEST_P4 (brain),
CDH17_E31 (kidney) and CRK_P721 (lung) were not
indicative of tissue origin in adult tissues (Figure 4). For
example, MEST_P4 was specifically hypomethylated in
fetal brain, but all adult tissues had an intermediate
level of DNA methylation, consistent with genomic
imprinting (Figure 4; see Additional file 1, Figure S4D).
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Figure 3 Venn diagram having the number of age-dependent methylated loci/genes between brain, kidney and lung. (A) Of 89 age-
dependent methylated loci (CpG sites), only four loci were common to different tissues. (B) Similarly, of the 75 associated genes in the 89 age-
dependent methylated loci, only four genes were common to different tissues. Most age-dependent differentially methylated regions (aDMRs)
were specific for one tissue, with 24 such loci identified in brain, 11 in kidney and 25 in lung. DMGs = differentially methylated genes. ↑ =
Hypermethylated; ↓ = Hypomethylated.
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function of genes that are differentially methylated
between fetus and adult, we carried out a Gene Ontology
(GO) analysis using DAVID (Database for Annotation,
Visualization and Integrated Discovery; http://david.abcc.
ncifcrf.gov/) [43,44]. Thus, we tested whether specific GO
terms of the genes associated with one or more aDMRs
were enriched compared with the GO distribution of all
the 752 autosomal genes associated with CpG sites pre-
sent on the array that we analyzed. Using this approach,
specific GO terms could be assigned to aDMR-associated
groups of genes in the three tissues. For brain, there was
no GO term enriched for the genes showing age-depen-
dent DNA methylation. For kidney, the enriched function
was ‘positive regulation of steroid metabolic process’ (P =
0.00057). Lastly, for lung, the function ‘ATP-binding’ (P =
0.0013) was enriched for the differentially methylated
genes. When we did a similar analysis of all aDMRs, irre-
spective of tissue origin, we found that those genes asso-
ciated with CpG sites that were hypomethylated in the
adult compared with fetus were enriched in the ‘nucleo-
tide-binding oligomerization domain (NOD)-like recep-
tor signaling pathway’ (P = 0.000017), whereas genes
associated with hypermethylated sites (increased DNA
methylation in the adult) were enriched for ‘embryonic
morphogenesis’ (P = 0.0019) (Table 2).
Characteristics of differentially methylated loci
DNA methylation has been associated with a variety of
histone markers and protein-binding targets [15-17].
Understanding how such features are associated with
the temporal changes in DNA methylation may provide
insight into the regulatory process(es) involved. To test
if any chromatin features set up during the embryonic
stem (ES) cell stage might affect the fate of tDMRs and
aDMRs, we also compared our DNA methylation data
with previously published studies of H3K4me3 and
H3K27me3 status and Polycomb group (PcG) protein-
binding targets in ES cells [45-47].
There were both similarities and differences in the epi-
genetic marks associated with adult tDMRs compared
with those associated with fetal tDMRs. The adult tDMRs
were deficient in H3K4me3 regions (P = 0.004) and CGI
(P < 0.0001), but were strikingly enriched in the loci that
contained neither H3K4me3 nor H3K27me3 compared
with all genes studied (P < 0.0001) (Figure 5A), which is
Table 2 Summary of differentially methylated loci between normal fetal and adult tissues
Tissue Number of
hyper
a loci
Number of
hypo
b loci
Total number of
aDMRs
c
Total number of
associated genes
GO
d terms P FDR
e,
%
Brain 17 21 38 36 - - -
Kidney 10 27 37 33 Positive regulation of steroid
metabolic process
0.00057 0.87
Transport 0.0042 4.7
Regulation of steroid metabolic
process
0.0031 4.7
Lung 9 38 47 39 ATP binding 0.0013 1.6
Positive regulation of steroid
metabolic process
0.0013 2
Positive regulation of lipid
metabolic process
0.0015 2.3
Adenyl ribonucleotide binding 0.0023 2.7
Transport 0.0026 3
Adenyl nucleotide binding 0.0028 3.3
Nucleoside binding 0.003 3.5
Purine nucleoside binding 0.003 3.5
Nucleotide-binding 0.0035 4
All
hyper
a,f
29 - 29 25 Embryonic morphogenesis 0.0019 2.8
All
hypo
b,f
- 60 60 50 NOD
g-like receptor signaling
pathway
0.000017 0.018
aHypermethylated.
bHypermethylated.
cAge-dependent differentially methylated regions.
dGene ontology.
eFalse discovery rate.
fRedundant loci eliminated
gNucleotide-binding oligomerization domain.
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Although fetal tDMRs displayed similar characteristics
(less prevalent in H3K4me3 regions (P = 0.006) and in
CGI (P < 0.0001), and more prevalent in regions with
neither H3K4me3 nor H3K27me3 (P < 0.0001)), they were
less likely to involve loci containing PcG-binding targets
(P = 0.006) and regions that were occupied by both
H3K4me3 and H3K27me3 (’bivalent’ regions) in ES cells
(P < 0.0001) (Figure 5A).
For the aDMRs, the hypermethylated loci were
enriched only in bivalent regions (P =0 . 0 3 )( F i g u r e5 B ) ,
whereas the hypomethylated loci were enriched in
regions lacking H3K4me3 or H3K27me3 (P < 0.0002) but
were reduced in PcG-binding regions (P < 0.03), bivalent
regions (P < 0.0002) and CGI (P < 0.0001) (Figure 5B).
The reduced number of hypomethylated loci in CGI
was also revealed by plotting the DNA methylation
distribution of all loci in CGI or non-CGI in fetus and
adult independently (see Additional file 1, Figure S6).
Comparison with ES cells identified dynamic DNA
methylation changes
The observed age-dependent DNA methylation changes
may represent a distinct temporal program or instead
simply reflect a continuum of change from ES cell to
fetus to adult. To determine if the fetal DNA methyla-
tion profile is largely intermediate between ES cell and
adult, we used the same array (GoldenGate Methylation
array; Illumina) to compare the identified aDMRs with
the DNA methylation pattern of 571 CpG sites in ES
cells, obtained from another study [31]. Multiple pat-
terns were seen, with DNA methylation levels at some
loci changing dynamically throughout development
(Figure 6; see Additional file 1, Figure S7). For example,
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Figure 4 Lack of conservation in tissue-specific differentially methylated loci between fetus and adult. Methylation level (b value) of (A)
MEST_P4 of the MEST gene, (B) CDH17_E31 of the CDH17 gene and (C) CRK_P721 of the CRK gene in fetal and adult tissues. Each bar
represents a different sample. Fetal tissue-specific indicator loci were not indicative of tissue origin in adult tissues.
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Page 8 of 15Figure 5 Characteristics of differentially methylated regions.C h a r a c t e r i s t i c so f(A) tissue-specific differentially methylated regions (tDMRs)
and (B) age-dependent differentially methylated regions (aDMRs). The characteristics of Polycomb complex binding targets and histone markers
were based on the previous report on embryonic stem cells whereas the information on CG islands (CGI) was available from Illumina. *P < 0.05,
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Page 9 of 15RAB32 was methylated de novo in the fetus from ES
cells but had loss of DNA methylation in adult tissue
(Figure 6A). By contrast, HPN had loss of DNA methy-
lation from ES cell to fetus, but was hypermethylated in
adult tissue (Figure 6B). This shows that DNA methyla-
tion changes dynamically during tissue development.
Discussion
The establishment and maintenance of tissue-specific
gene-expression profiles during development of multicel-
lular organisms is tightly linked to a network of transcrip-
tion factors and epigenetic modifications. Among the
latter, DNA methylation is currently best understood,
with a large number of tDMRs having been identified
[1,17,18,22,30,48], primarily in adult tissues. In particular,
a recent high-throughput DNA methylation study of
11 somatic tissues from six people (aged 35 to 60 years)
provided valuable data for adult tissue- and individual-
specific DNA methylation patterns [30]. In this study, we
present several findings relevant to assessing the contri-
bution of DNA methylation to tissue specificity during
the course of normal and abnormal development.
First, we found clustering of fetal tissues according to
their DNA methylation patterns, and identified DNA
methylation markers that are indicative of tissue origin.
Second, although distinct significantly altered DNA
methylation markers were present in the skin of fetuses
with trisomy 18 and trisomy 21, these differences overall
were much less dramatic than tissue- and age-related
effects. Third, DNA methylation in adult tissues was
remarkably different from that in fetal tissues, with
these age-dependent changes most often being tissue-
specific. This was also true for imprinted loci, suggesting
an unexpected plasticity of these classic epigenetic mar-
kers. Lastly, the dynamic nature of DNA methylation
markers became even more evident through compari-
sons with ES cells, with the most plastic regions being
linked to bivalent histone-modification domains. Collec-
tively, this work not only complements recent studies
identifying DNA methylation changes during aging in
blood, but also expands the age range of epigenetic
interrogations in somatic tissues, as these have been pre-
viously primarily been carried out on adult tissues.
Using an array-based approach, we were able to
establish tissue-specific patterns of DNA methylation
in fetuses from second-trimester terminations. Unsu-
pervised clustering clearly separated the five tissues
examined here, confirming that distinct patterns of
DNA methylation occur during early embryonic or
fetal development. Consistent with this, 23% of all sites
included in the analysis were significantly different
between tissues, and were thus classified as tDMRs.
Interestingly, tDMRs were more likely to reside in
regions of low CpG density as opposed to CGIs, indi-
cating that these regions are particularly receptive for
the establishment of tissue-specific DNA methylation
markers.
Although fetal tissue-specific DNA methylation was
generally maintained in pathological conditions caused
by T18 and T21, these chromosomal abnormalities were
associated with epigenetic differences. Specifically, we
identified 17 hypermethylated loci in the T18, seven in
T21 skin, and one in T21 muscle. Interestingly, none of
the loci with an altered DNA methylation pattern was
located on the affected chromosome (chromosome 18
or 21). This suggests that the extra chromosome may
exert a trans-acting effect to change the overall epige-
netic patterning of the genome, which is consistent with
the global disruption in gene expression reported in
association with trisomy and in a recent study of gen-
ome-wide DNA methylation of leukocytes with T21
[25-27,49]. Many of the differentially methylated genes
were related to developmental processes and immune
response, perhaps reflecting an important functional dif-
ference between normal and trisomic tissues. The lack
of obvious DNA methylation differences in brain, kidney
and lung between normal and trisomic fetuses may be
in part because of our somewhat low sample size (four
cases of T18 and five cases of T21) or the relatively
small number of CpG loci interrogated here.
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Figure 6 Dynamic changes of DNA methylation. (A) RAB32_P493
had hypermethylation in fetal brain, but hypomethylation in
embryonic stem (ES) cells and adult brain. (B) HPN_P823 had
hypermethylation in ES cells and adult kidney, but hypomethylation
in fetal kidney.
Yuen et al. Epigenetics & Chromatin 2011, 4:7
http://www.epigeneticsandchromatin.com/content/4/1/7
Page 10 of 15In contrast to the relatively subtle changes in DNA
methylation associated with the two trisomies, changes
in DNA methylation occurring over time in normal
development were much more pronounced. In total,
10% of the investigated genes had striking changes in
DNA methylation between somatic tissues (brain, lung
and kidney) of second-trimester fetus compared with
adult. Because we used a high statistical stringency to
avoid technical artifacts, even more differences would be
expected if less strict criteria were used. Although the
cellular composition of each tissue may also change
with time, the dramatic differences in DNA methylation
between fetus and adult would require major changes in
cell composition to explain it. However, it is worth not-
ing that the study was based on the comparison between
fetal samples originating from a small time window,
with adult samples having a wide age range (age 35 to
60 years), so there is naturally greater variation in the
age of adults than in second-trimester fetuses. This may
explain the wider variation in DNA methylation seen in
adult tissues (Figure 4). A comparison of DNA methyla-
tion profiles of adult somatic tissues between two
published data sets using the same (GoldenGate) methy-
lation array gave high correlations between the same tis-
sues (r = 0.99 for brain, r = 0.98 for both kidney and
l u n g )[ 2 2 , 3 0 ] .I na d d i t i o n ,t h e r ew a sa tm o s to n l yo n e
site for each tissue with an average b value difference
>0.4 between two data, supporting that the fetal-to-adult
difference we found was more profound than can be
explained by batch effects. Furthermore, although single
nucleotide polymorphisms (SNPs) and sequence repeats
overlapping with some probes present on the array may
potentially interfere with DNA methylation analysis [30],
DNA sequence polymorphisms would be unlikely to
cause the consistently large DNA methylation differ-
ences seen between groups. In accordance with this, we
did not find any enrichment of known SNPs or repeats
located in the differentially methylated loci we identified
(P = 0.92).
Focusing more specifically on the tDMRs that differ
between fetal and adult tissues supports the existence of
extensive reprogramming of the epigenome occurring
during development. Many tDMRs (~80%) identified in
fetus were no longer distinctly methylated in the same
tissue-specific pattern in adult. This suggests that the tis-
sue-specific DNA methylation, and probably the expres-
sion, of these genes is required only at an early stage of
development and thus is not maintained in the adult. It
is possible that the loss of fetal tDMRs was due either to
the reduced function of DNA methyltransferases [50], or
to responses to the changing environmental influences,
and/or to stochastic changes that occur over time [22].
However, the emergence of some tDMRs in adult that
were not present in the fetus suggests that tDMRs also
result from major programmed developmental changes
occurring postnatally.
One clue to the significance of reprogramming of
tDMRs might emerge from the differences in associated
biological functions, depending on whether these
tDMRs were hypo- or hypermethylated in adult relative
to fetus. The age-dependent hypermethylated loci
(that is, those that are most probably associated with
decreased gene expression in the adult) were enriched
for genes involved in embryonic morphogenesis, perhaps
reflecting a decreased need for such genes to be
expressed in fully differentiated adult tissue. Age-depen-
dent hypomethylated loci were enriched for immune-
response pathways, which may reflect the general activa-
tion of the immune system after birth.
Mechanistically, chromatin features set in ES cells
might be linked to developmental plasticity of tDMRs.
Both fetal and adult tDMRs were more prevalent in
areas lacking H3K4me3 or H3K27me3, suggesting that
tDMRs may be identified by epigenetic markers other
than H3K4me3 or H3K27me3. Specifically, tDMRs from
fetal tissues were less enriched for bivalent chromatin
domains, which are characterized by the coexistence
of an activating H3K4me3 marker and repressive
H3K27me3 marker. These domains probably function to
silence genes encoding developmental regulators, while
simultaneously keeping them ‘poised’ for activation in
ES cells [29]. Fetal tDMRs also less often contained PcG
protein-binding regions, another hallmark of bivalent
domains. PcG proteins are important regulators of cellu-
lar development and differentiation [47]. By contrast,
there was no significant enrichment of either bivalent
chromatin domains or PcG protein-binding regions in
adult tDMRs. Together, these findings suggest two con-
clusions. First, tDMRs present at the fetal stage might
regulate processes other than differentiation. Second,
the mechanism for tissue-specific regulation of gene
expression might differ between developmental stages.
However, these conclusions should be taken with cau-
tion, given that the actual DNA methylation status of
the ES cells being investigated was not taken into
account in our study. Further investigation is needed to
confirm our conclusions.
These principles are further supported by the observa-
tion that CpG loci undergoing DNA methylation
changes between fetal and adult tissues often have a dis-
tinct DNA methylation pattern in ES cells. For example,
whereas it might be expected that de novo DNA methy-
lation of genes bound by PcG proteins in ES cells would
be irreversible, in order to permanently silence their
expression, we in fact found dramatic plasticity at these
loci during development. This is well illustrated by
RAB32, which had a considerable increase in DNA
methylation during the transition from ES cells to fetal
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Page 11 of 15brain, but then lost DNA methylation in the adult tis-
sues. Thus, DNA methylation is not only reversible dur-
ing development, but can be changed in a non-linear,
dynamic fashion throughout life. These changes may
occur through passive or active processes. These data
have important practical implications for DNA methyla-
tion studies. Specifically, the developmental plasticity of
DNA methylation emphasizes the necessity of using
age-matched case-control subjects for epigenetic studies,
and considering in what age group the hypothesized
differences might be most apparent.
In addition to bivalent chromatin domains being asso-
ciated with differences between fetal and adult tDMRs,
we identified several imprinted loci associated with dif-
ferential DNA methylation during development. In gen-
eral, imprinted genes are associated with DMRs that
exhibit ~50% DNA methylation, corresponding to their
parent-of-origin allelic gene expression pattern. These
DMRs are generally classified as either primary
(gametic) imprints, which are inherited from the
gametes and maintained throughout tissue differentia-
tion, or secondary DMRs, which are generally believed
to be acquired before or during tissue differentiation
[13]. Although it has been reported that DNA methyla-
tion of imprinted genes can change moderately during
aging [22,51], and tissue- and developmental-specific
imprinting of Igf2 has been reported in the mouse [52],
this may be more common than previously appreciated.
In this study, we found strong evidence for an erosion
of methylation over time for CpGs associated with the
promoter regions of several imprinted genes such as
GABRB3 and ZNF264, having an average of ~50%
methylation in the fetus, but only ~5% in various adult
tissues (for some sites this occurred in all tissues,
whereas for other sites, it occurred only in one specific
tissue). Interestingly, GABRB3 is biallelically expressed
in normal brain, including in newborns, but is imprinted
in some cases of autistic spectrum disorders [39].
Although we did not measure allelic expression of
GABRB3 in our fetal samples, the DNA methylation
of approximately 50% at the GABRB3 locus is indicative
of it being imprinted early in fetal development. This
then suggests that the early imprinting would have to be
erased in brain perinatally to establish biallelic gene
expression reported in newborns and adults. Although
speculative, it is interesting to consider that autistic dis-
orders might be linked to the maintenance of parent-of-
origin allelic expression of GABRB3, as a result of failure
to erase the fetal imprint.
In addition to loss of imprinting, we also identified
gain of DNA methylation at imprinted loci, suggesting
that imprinting can be established later in development
long after tissue differentiation. For example, MEST was
unmethylated in fetal brain and highly methylated in
fetal lung, but had the expected 50% DNA methylation
in both adult brain and lung. Thus, DMRs associated
with imprinted genes can not only be tissue-specific but
also modulated during the transition from second trime-
ster to postnatal development. This unexpected plasti-
city raises the possibility that the number of imprinted
genes in our genome may greatly exceed those yet iden-
tified, as the correct tissue and time point in develop-
ment may need to be assessed to detect their presence.
Conclusions
Although the full biological significance of dynamic
changes in tissue-specific DNA methylation over time
has yet to be elucidated, the patterns and magnitude of
differences indicate many of the changes seen here are
programmed rather than stochastic changes (Figure 7).
Obtaining well-matched normal human samples over
different developmental stages is difficult, thus more
detailed investigations in model organisms such as
mouse are needed. Nonetheless, the investigation of
fetal pathologies such as T18 and T21 cannot be fully
replicated in other organisms, and these results suggest
that epigenetic changes between disease groups can be
identified, as long as there is careful control for all
confounding factors such as gestational age and consid-
eration of the effects of tissue composition. These data
also suggest that caution should be used in applying
DNA methylation analysis to prenatal diagnosis (for
example, to diagnose disorders of genomic imprinting)
without prior confirmatory studies demonstrating the
predictive value of such prenatally determined DNA
methylation.
Methods
The study was approved by the ethics committees of the
University of British Columbia and the Children’s&
Women’s Health Centre of British Columbia.
Sample collection
Fetal tissues (muscle, skin, kidney, lung and brain) were
obtained from anonymous, chromosomally normal, sec-
ond-trimester (15-24 weeks in gestational age, mostly
19-20 weeks) fetuses from elective terminations for
medical reasons (that is, termination for premature rup-
ture of membranes or diaphragmatic hernia). Only
information on gestational age and reason for pregnancy
termination was recorded. All were either dilation or
evacuation, with the extractions being of intact fetuses
or inductions of labor, which results in delivery of an
intact fetus. Samples were collected by the Children’s
and Women’s Pathology laboratory at post-mortem
examination as follows: skin (normally abdominal area),
kidney (one-quarter of a kidney including the cortex
and medulla), brain (cerebrum), lung (small sample
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Page 12 of 15from the edges) and muscle (psoas muscle). Genomic
DNA was extracted from each tissue sample using stan-
dard techniques. Samples from pregnancy terminations
for T18 and T21 were obtained in a similar manner for
comparison. No discernible growth delay was seen in
the trisomic fetuses, and the age distribution was similar
for trisomies and controls.
DNA methylation array
Bisulfite conversion of 750 ng of genomic DNA was per-
formed using a commercial kit (EZ DNA Methylation
Kit; Zymo Research, Orange, CA, USA) according to the
manufacturer’s instructions. After bisulfite treatment,
unmethylated cytosines were converted to uracils,
whereas methylated cytosines were not changed. Bisul-
fite-converted DNA samples were subjected to an array-
based array (Illumina GoldenGate Methylation Cancer
Panel I; Illumina) as described in our previous studies
[32,33]. All samples were run on the same chip (Gold-
enGate; Illumina) to avoid and chip or batch effects.
This platform is well-validated, and its use allowed us to
compare our data to that in the literature. The array
specifically targets promoter regions of the genes (1.5 kb
upstream and 500 bp downstream from the transcrip-
tion start site), and the location of specific sites is well
annotated in the probe database (Illumina). Briefly, two
allele-specific probes were designed for each CpG site
o nt h ea r r a y :o n ef o rt h em e t h y l a t e ds e q u e n c ea n do n e
for the unmethylated sequence. After annealing to the
target sequence, the probes were extended and ligated
to locus-specific oligomers. The ligated products were
then amplified by PCR using fluorescently labelled pri-
mers, and hybridized to the bead array. The methylation
levels for each CpG sites were measured as the intensity
of fluorescent signals corresponding to the methylated
allele (Cy5) and the unmethylated allele (Cy3). Cy5 and
Cy3 fluorescent intensities were corrected independently
for background signal and normalized using specialized
software (BeadStudio; Illumina). Continuous b values,
ranging from 0 (unmethylated) to 1 (methylated) were
used to denote the percentage of DNA methylation,
from 0% to 100%, for each CpG site. The detection
Normal fetus
N=6
(brain, kidney, lung, 
muscle, skin)
Normal adult
N=6
(brain, kidney, lung)
ES cells
N=8
195 tDMRs
89 aDMRs:
-60 hyper- and 29 hypo-
methylated in adult
Few significant differences:
-17 hypermethylated in T18 skin
-7 hypermethylated in T21 skin
-1 hypermethylated in T21 muscle
3 patterns observed:
1) De novo methylation
2) Demethylation
3) Dynamic methylation 
(transient methylation or 
demethylation in fetus)
Fetal between tissue 
comparison
-834 probes
Fetal vs. adult 
brain:     756 probes
kidney:  1026 probes
lung:       849 probes
ES cells vs. fetal and adult
-571 probes
Trisomy 18 
and 21
T18: N=4
T21: N=5
(brain, kidney, lung, 
muscle, skin)
Trisomy vs. Normal:
T21: 852 probes
T18: 894 probes
Figure 7 Summary of data and findings in this study. Number of probes and tissues is shown for each comparison between sample groups.
A brief description of main findings is included.
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Page 13 of 15P value of each probe was generated by comparison
with a series of negative controls embedded in the assay.
Probes with a detection P value of > 0.05 in any of the
samples were eliminated from the study. Furthermore,
to concentrate on substantially altered sites and to
reduce the statistical complexities associated with large
numbers of tests being performed on a small sample set,
C p Gl o c it h a tw e r ec o n s i d e r e dt ob en o n - v a r i a n t( b
values <0.1 or >0.9 in all samples) were eliminated from
the analyses. This was performed throughout the study,
but it yielded different numbers depending on the indi-
vidual comparison, because of the different number of
invariant probes in each comparison.
Statistical analysis
Tissue-specific, differentially methylated regions in fetus
and adult tissues were identified by ANOVA for significant
CpG loci after Bonferroni correction using statistical soft-
ware (SPSS; SPSS Inc., Chicago, IL, USA). Loci that were
differentially methylated between normal and trisomy fetal
tissues, and between normal fetal and adult tissues were
identified using SAM, with a cut-off FDR of <5%. Charac-
teristics of DNA methylation in tDMRs and aDMRs were
analyzed by the Pearson c
2 test. The Pearson linear corre-
lation was used to analyze the similarities between tissue
samples of average DNA methylation at each autosomal
locus. The DAVID program was used for GO analysis
[43,44]. Using the total number of genes presented in the
array as a background for comparison, enriched GO terms
were identified using a cut-off FDR of <5%.
Bisulfite pyrosequencing
Loci identified with tissue-specific DNA methylation in
fetal tissues were confirmed using bisulfite pyrosequen-
cing, performed on a pyrosequencer (Pyromark™ Q96
MD; Biotage, Uppsala, Sweden) and the quantitative
levels of methylation for each CpG dinucleotide were
evaluated with the manufacturer’ss o f t w a r e( P y r o
Q-CpG software; Biotage). DNA methylation-unbiased
pyrosequencing primers covering the same CpG sites
interrogated by the Illumina probes and their assay con-
ditions are listed (see Additional file 2, Table S4).
Additional material
Additional file 1: Figure S1 to S7
Additional file 2: Table S1 to S4
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